Portfolio company
Refined Diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
SamanTree Medical
This company develops digital microscopy scanners for surgeons and pathologists to perform real-time assessment of fresh tissue samples during cancer surgery.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Hypervision Surgical
The company develops an artificial intelligence powered hyperspectral imaging platform that provides real-time tissue analysis for surgeons during medical procedures.
Digistain
This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.
Refined Laser Systems
This company develops ultrafast laser systems and intraoperative microscopes for researchers and clinicians working in cancer diagnostics and quantum technology.
Ravada Health
This company develops artificial intelligence and hardware to transform MRI scanners into non-invasive pathology platforms for biopsy-saving prostate cancer diagnostics.
EnAcuity
This company develops artificial intelligence software that provides real-time hyperspectral imaging for surgeons performing minimally invasive procedures.
